AMRN NASDAQ
Credit Risk of going bust: lower than 84% of companies Debt: 2.1% of company value Bonds: none of note held by US funds details ▾
Total debt $5.3M against a stock market value of $247.2M.
Distance to default 11.00 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.6M (short-term plus half of long-term), stock volatility 41.4%; Altman Z'' -2.07. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Dublin, DU D02 K7K5
IE
Amarin Corporation plc is a pharmaceutical firm dedicated to the research, development, and commercialization of therapeutic solutions for cardiovascular diseases. Its operations span several international regions, including the United States, Germany, Canada, Lebanon, and the United Arab Emirates. The company's flagship product is VASCEPA, an omega-3 fatty acid formulation available by prescription only. This medication acts as an adjunctive therapy to diet, designed to decrease elevated triglyceride levels in adult patients suffering from severe hypertriglyceridemia. Amarin primarily distributes its offerings through wholesale channels and specialized pharmacy providers. Furthermore, the company has entered into a collaboration with Mochida Pharmaceutical Co., Ltd. to advance the development and market introduction of drug products and new indications derived from Vascepa's active pharmaceutical ingredient, which encompasses omega-3 acid and eicosapentaenoic acid. Established in 1989 as Ethical Holdings plc, the organization rebranded to Amarin Corporation plc in 1999. Its corporate headquarters are located in Dublin, Ireland.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Fishman Peter L. | M-Exempt | 313 | — | 2026-08-01 |
| Fishman Peter L. | F-InKind | 155 | $14.26 | 2026-08-01 |
| Fishman Peter L. | A-Award | 313 | — | 2026-08-01 |
| Fishman Peter L. | M-Exempt | 2,447 | — | 2026-07-01 |
| Fishman Peter L. | F-InKind | 1,206 | $15.94 | 2026-07-01 |